Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Completed · Phase 2

Conditions studied: Tularemia

In brief

This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine

Key facts

Study ID

NCT00584844

Run by

U.S. Army Medical Research and Development Command

People needed

484

Starts

2004-10-01

Expected to finish

2013-10-01

Last updated by the study team

2020-01-02

Who can join

Age: 17 and older, up to 65. Sex: any. Healthy volunteers: accepted.

Where it is running

• U.S. Army Medical Research Institute of Infectious Diseases — Fort Deterick, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.